Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ching-I Huang

Showing results (131-140 of 156) with videos related to

Pageof 16
Sort By:
Oncotarget|August 20, 2016
Dynamics of PBMC gene expression in hepatitis C virus genotype 1-infected patients during combined peginterferon/ribavirin therapyMing-Ying Lu, Ching-I Huang, Ming-Yen Hsieh, et al.
Medicine|June 1, 2017
Identification of groups with poor cost-effectiveness of peginterferon plus ribavirin for naïve hepatitis C patients with a real-world cohort and databasePei-Chien Tsai, Ta-Wei Liu, Yi-Shan Tsai, et al.
Plos One|February 4, 2021
Concordance of SVR12, SVR24 and SVR durability in Taiwanese chronic hepatitis C patients with direct-acting antiviralsChuan-Pin Lin, Po-Cheng Liang, Ching-I Huang, et al.
Journal of Clinical and Translational Hepatology|August 14, 2023
Community-centered Disease Severity Assessment of Metabolic Dysfunction-associated Fatty Liver DiseaseJee-Fu Huang, Pei-Chien Tsai, Ming-Lun Yeh, et al.
ACS Nano|January 1, 2013
Band gap engineering of chemical vapor deposited graphene by in situ BN dopingCheng-Kai Chang, Satender Kataria, Chun-Chiang Kuo, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|April 9, 2017
Identification of treatment-experienced hepatitis C patients with poor cost-effectiveness of pegylated interferon plus ribavirin from a real-world cohortTa-Wei Liu, Pei-Chien Tsai, Ching-I Huang, et al.
The Kaohsiung Journal of Medical Sciences|November 9, 2023
Patient-centered and integrated outreach care for chronic hepatitis C patients with serious mental illness in TaiwanChung-Feng Huang, Tyng-Yuan Jang, Shun-Chieh Yu, et al.
Clinical Kidney Journal|December 4, 2023
Therapy as prevention toward HCV elimination in maintenance hemodialysis: a multi-center, prospective cohort studyChung-Feng Huang, Chia-Yen Dai, Chih-Wen Wang, et al.
Gut|December 11, 2020
Establishment of an outreach, grouping healthcare system to achieve microelimination of HCV for uremic patients in haemodialysis centres (ERASE-C)Ming-Lung Yu, Chung-Feng Huang, Yu-Ju Wei, et al.
American Journal of Cancer Research|February 13, 2023
Decision tree algorithm predicts hepatocellular carcinoma among chronic hepatitis C patients following viral eradicationMing-Ying Lu, Ta-Wei Liu, Po-Cheng Liang, et al.
Pageof 16

Showing results (131-140 of 156) with videos related to

Sort By:
Pageof 16
Oncotarget|August 20, 2016
Dynamics of PBMC gene expression in hepatitis C virus genotype 1-infected patients during combined peginterferon/ribavirin therapyMing-Ying Lu, Ching-I Huang, Ming-Yen Hsieh, et al.
Medicine|June 1, 2017
Identification of groups with poor cost-effectiveness of peginterferon plus ribavirin for naïve hepatitis C patients with a real-world cohort and databasePei-Chien Tsai, Ta-Wei Liu, Yi-Shan Tsai, et al.
Plos One|February 4, 2021
Concordance of SVR12, SVR24 and SVR durability in Taiwanese chronic hepatitis C patients with direct-acting antiviralsChuan-Pin Lin, Po-Cheng Liang, Ching-I Huang, et al.
Journal of Clinical and Translational Hepatology|August 14, 2023
Community-centered Disease Severity Assessment of Metabolic Dysfunction-associated Fatty Liver DiseaseJee-Fu Huang, Pei-Chien Tsai, Ming-Lun Yeh, et al.
ACS Nano|January 1, 2013
Band gap engineering of chemical vapor deposited graphene by in situ BN dopingCheng-Kai Chang, Satender Kataria, Chun-Chiang Kuo, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|April 9, 2017
Identification of treatment-experienced hepatitis C patients with poor cost-effectiveness of pegylated interferon plus ribavirin from a real-world cohortTa-Wei Liu, Pei-Chien Tsai, Ching-I Huang, et al.
The Kaohsiung Journal of Medical Sciences|November 9, 2023
Patient-centered and integrated outreach care for chronic hepatitis C patients with serious mental illness in TaiwanChung-Feng Huang, Tyng-Yuan Jang, Shun-Chieh Yu, et al.
Clinical Kidney Journal|December 4, 2023
Therapy as prevention toward HCV elimination in maintenance hemodialysis: a multi-center, prospective cohort studyChung-Feng Huang, Chia-Yen Dai, Chih-Wen Wang, et al.
Gut|December 11, 2020
Establishment of an outreach, grouping healthcare system to achieve microelimination of HCV for uremic patients in haemodialysis centres (ERASE-C)Ming-Lung Yu, Chung-Feng Huang, Yu-Ju Wei, et al.
American Journal of Cancer Research|February 13, 2023
Decision tree algorithm predicts hepatocellular carcinoma among chronic hepatitis C patients following viral eradicationMing-Ying Lu, Ta-Wei Liu, Po-Cheng Liang, et al.
Pageof 16